drugset / Trial / NCT05333302
Pilot CAR-T Cells Therapy for Children/Young Adults With CD19+ R/R Leukemia/Lymphoma
Phase 1
Recruiting
10 enrolled
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to estimate the safety and the efficacy of CAR- T cells immunotherapy for children/young adults with relapsed or refractory acute lymphoblastic leukemia/lymphoma.
Timeline
- Start
- 2020-10-26
- Primary completion
- 2024-12
- Completion
- 2025-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CD19 CAR-T cells | Cell therapy | 1e+06 cells/kg | Intravenous |
| Background | Tocilizumab | Monoclonal antibody | 8 mg/kg | — |